Bernstein Liebhard LLP announced that a securities class action lawsuit has been filed against GeneDx Holdings Corp. on behalf of investors who purchased or acquired common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that defendants made materially false and misleading statements about the company's business operations, growth prospects, and financial stability, causing the stock to trade at artificially inflated prices. When the truth was disclosed, investors allegedly suffered significant losses. Investors have until August 3, 2026 to file papers to serve as lead plaintiff.
GeneDx Holdings Corp.Securities class action lawsuit alleging false statements about business operations and financial stability.